Coffee and caffeine as a cognitive enhancer in multiple sclerosis; a systematic review

Coffee and caffeine as a cognitive enhancer in multiple sclerosis; a systematic review


چاپ صفحه
پژوهان
صفحه نخست سامانه
نویسندگان
نویسندگان
اطلاعات تفضیلی
اطلاعات تفضیلی
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: سامان بهارامید , سینا پاک خصال , مریم بال افکنده , سروین سنایی اسکویی , امیررضا ناصری

عنوان کنگره / همایش: 21st National Multiple Sclerosis Congress of IRAN , Iran (Islamic Republic) , تهران , 2024

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله امیررضا ناصری
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه کمیته تحقیقات دانشجویی
کد مقاله 86523
عنوان فارسی مقاله Coffee and caffeine as a cognitive enhancer in multiple sclerosis; a systematic review
عنوان لاتین مقاله Coffee and caffeine as a cognitive enhancer in multiple sclerosis; a systematic review
نوع ارائه پوستر
عنوان کنگره / همایش 21st National Multiple Sclerosis Congress of IRAN
نوع کنگره / همایش ملی
کشور محل برگزاری کنگره/ همایش Iran (Islamic Republic)
شهر محل برگزاری کنگره/ همایش تهران
سال انتشار/ ارائه شمسی 1403
سال انتشار/ارائه میلادی 2024
تاریخ شمسی شروع و خاتمه کنگره/همایش 1403/09/14 الی 1403/09/16
آدرس لینک مقاله/ همایش در شبکه اینترنت
آدرس علمی (Affiliation) نویسنده متقاضی Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

نویسندگان
hide/show

نویسنده نفر چندم مقاله
سامان بهارامیددوم
سینا پاک خصالسوم
مریم بال افکندهچهارم
سروین سنایی اسکوییپنجم
امیررضا ناصریششم

اطلاعات تفضیلی
hide/show

عنوان متن
کلمات کلیدیCoffee; Caffeine; Multiple sclerosis; Cognition; Cognition Disorders; Systematic review.  
خلاصه مقالهBackground and aims: Cognitive dysfunction is prevailing among multiple sclerosis (MS) patients. As the most widely consumed psychoactive substance, this investigation aims to estimate the potential of coffee and caffeine as a cognitive enhancer in MS patients. Methods: This study was conducted following the Joanna Briggs Institute (JBI) Manual for Evidence Synthesis and PRISMA 2020 statement. A systematic search was performed in PubMed, Scopus, Web of Science, and Embase in October 2023, and updated via handsearching in March 2024. JBI's critical appraisal tools were utilized to scrutinize the risk of bias. Results: Out of 297 screened records, four studies were eventually found to meet our inclusion criteria. A single-blind crossover trial (n=12) showed short-term caffeine abstinence increased errors on the Stroop cognitive test and also a retrospective cohort study (n=124) found higher coffee intake was associated with subjectively better concentration and attention in MS patients. A small pilot cohort study (n=63) reported better verbal learning and memory performance among MS patients with higher daily coffee consumption, however, a cross-sectional study (n=126) study did not find significant effects of coffee/caffeine intake on other cognitive test measures. Conclusions: Evidence indicates an association between caffeine and coffee consumption, and improved cognitive outcomes, which suggests a domain-specific cognitive effectiveness for this substance in MS. Considering the small number of examinations and great diversity in assessed outcomes, the findings of this study should translate to clinical practice with great notice.

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
38.pdf1403/10/18415752دانلود
Coffee.jpeg1403/10/181605014دانلود